Gustavo A. Rosario Benitez

Array ( [id] => 4513486 [patent_doc_number] => 07931901 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-26 [patent_title] => 'T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/510868 [patent_app_country] => US [patent_app_date] => 2006-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19253 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/931/07931901.pdf [firstpage_image] =>[orig_patent_app_number] => 11510868 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373667 [patent_doc_number] => 20090311228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'TREATMENT OF INFLAMMATORY BOWEL DISEASE' [patent_app_type] => utility [patent_app_number] => 12/065047 [patent_app_country] => US [patent_app_date] => 2006-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4781 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311228.pdf [firstpage_image] =>[orig_patent_app_number] => 12065047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887524 [patent_doc_number] => 20060275258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Interferon-alpha induced gene' [patent_app_type] => utility [patent_app_number] => 11/503770 [patent_app_country] => US [patent_app_date] => 2006-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7538 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275258.pdf [firstpage_image] =>[orig_patent_app_number] => 11503770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5887614 [patent_doc_number] => 20060275292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-07 [patent_title] => 'Fully human anti-CD3 monoclonal antibodies' [patent_app_type] => utility [patent_app_number] => 11/502870 [patent_app_country] => US [patent_app_date] => 2006-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4429 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20060275292.pdf [firstpage_image] =>[orig_patent_app_number] => 11502870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8920762 [patent_doc_number] => 08486694 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-16 [patent_title] => 'Generation of antigen specific T cells' [patent_app_type] => utility [patent_app_number] => 11/990054 [patent_app_country] => US [patent_app_date] => 2006-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 14918 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11990054 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6631025 [patent_doc_number] => 20100035282 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-11 [patent_title] => 'USE OF COMMON GAMMA CHAIN CYTOKINES FOR THE VISUALIZATION, ISOLATION AND GENETIC MODIFICATION OF MEMORY T LYMPHOCYTES' [patent_app_type] => utility [patent_app_number] => 12/063373 [patent_app_country] => US [patent_app_date] => 2006-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 22705 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20100035282.pdf [firstpage_image] =>[orig_patent_app_number] => 12063373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4494989 [patent_doc_number] => 07947464 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Method for identifying regulatory T cells' [patent_app_type] => utility [patent_app_number] => 11/989933 [patent_app_country] => US [patent_app_date] => 2006-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 20882 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947464.pdf [firstpage_image] =>[orig_patent_app_number] => 11989933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4493654 [patent_doc_number] => 07947272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-24 [patent_title] => 'Compositions and methods of tolerizing a primate to an antigen' [patent_app_type] => utility [patent_app_number] => 11/486293 [patent_app_country] => US [patent_app_date] => 2006-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14548 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/947/07947272.pdf [firstpage_image] =>[orig_patent_app_number] => 11486293 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5050875 [patent_doc_number] => 20070031420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'MASP-2, a complement-fixing enzyme, and uses for it' [patent_app_type] => utility [patent_app_number] => 11/476754 [patent_app_country] => US [patent_app_date] => 2006-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16060 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20070031420.pdf [firstpage_image] =>[orig_patent_app_number] => 11476754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5193511 [patent_doc_number] => 20070081995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Methods and compositions for targeting IFNAR2' [patent_app_type] => utility [patent_app_number] => 11/472534 [patent_app_country] => US [patent_app_date] => 2006-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 29005 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20070081995.pdf [firstpage_image] =>[orig_patent_app_number] => 11472534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7573082 [patent_doc_number] => 20110268738 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-03 [patent_title] => 'Antibodies Against Hmgb1 and Fragments Thereof' [patent_app_type] => utility [patent_app_number] => 11/922259 [patent_app_country] => US [patent_app_date] => 2006-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 14396 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20110268738.pdf [firstpage_image] =>[orig_patent_app_number] => 11922259 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4530543 [patent_doc_number] => 07887811 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Method for preparing a stable immunogenic product comprising antigenic heterocomplexes of TNFα and a carrier protein' [patent_app_type] => utility [patent_app_number] => 11/915044 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20464 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 306 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/887/07887811.pdf [firstpage_image] =>[orig_patent_app_number] => 11915044 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807469 [patent_doc_number] => 20080171047 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Methods of Treating Graft Versus Host Disease' [patent_app_type] => utility [patent_app_number] => 11/913409 [patent_app_country] => US [patent_app_date] => 2006-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17874 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171047.pdf [firstpage_image] =>[orig_patent_app_number] => 11913409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5440904 [patent_doc_number] => 20090092543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-09 [patent_title] => 'Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells' [patent_app_type] => utility [patent_app_number] => 11/918711 [patent_app_country] => US [patent_app_date] => 2006-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 24584 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20090092543.pdf [firstpage_image] =>[orig_patent_app_number] => 11918711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834212 [patent_doc_number] => 20060246042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Cells, culture methods, and their use in autologous transplantation therapy' [patent_app_type] => utility [patent_app_number] => 11/400767 [patent_app_country] => US [patent_app_date] => 2006-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10798 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246042.pdf [firstpage_image] =>[orig_patent_app_number] => 11400767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751952 [patent_doc_number] => 20080160025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Use of Calcitonin as Combined Treatment Therapy for the Management of Inflammatory Disease Conditions' [patent_app_type] => utility [patent_app_number] => 11/910023 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4610 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160025.pdf [firstpage_image] =>[orig_patent_app_number] => 11910023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5655215 [patent_doc_number] => 20060140950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Uses of mammalian cytokine; related reagents' [patent_app_type] => utility [patent_app_number] => 11/359269 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19605 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0140/20060140950.pdf [firstpage_image] =>[orig_patent_app_number] => 11359269 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101850 [patent_doc_number] => 07722873 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Heterologous antibodies which bind human CD4' [patent_app_type] => utility [patent_app_number] => 11/349724 [patent_app_country] => US [patent_app_date] => 2006-02-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 99 [patent_figures_cnt] => 113 [patent_no_of_words] => 84911 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/722/07722873.pdf [firstpage_image] =>[orig_patent_app_number] => 11349724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4839328 [patent_doc_number] => 20080279813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-13 [patent_title] => 'Cd4+ Cd25+ T-Cells Activated to a Specific Antigen' [patent_app_type] => utility [patent_app_number] => 11/815420 [patent_app_country] => US [patent_app_date] => 2006-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 40988 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0279/20080279813.pdf [firstpage_image] =>[orig_patent_app_number] => 11815420 [rel_patent_id] =>[rel_patent_doc_number] =>)